Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

India Plans To Sell Generic Cancer, CV Drugs At Hefty Discounts

This article was originally published in PharmAsia News

Executive Summary

India has announced a pilot scheme to sell hundreds of generic cancer and cardiovascular drugs, as well as cardiac implants, at levels at least 50% below normal retail prices through government-run outlets, in a drive to make important medicines more affordable to its vast population.



Related Companies